Nov 28 (Reuters) - Vita Life Sciences Ltd (VLS) :
- SEES FY2022 PRE-TAX PROFIT OF A$9.5-10.0M
- SEES SALES OF A$64.0 MILLION-A$65.0 MILLION FOR FY22
- MARKET CONDITIONS ACROSS COMPLEMENTARY MEDICINE CATEGORIES CONTINUE TO REMAIN STRONG
- SOFTER TRADING CONDITIONS ARE EXPECTED IN 1H2023 ACROSS COMPLEMENTARY MEDICINE CATEGORIES
News: VLS Vita Life Sciences Says Expects FY2022 Pre-Tax Profit Of A$9.5-10.0 Mln
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.48 |
Change
0.030(1.22%) |
Mkt cap ! $136.3M | |||
| Open | High | Low | Value | Volume |
| $2.45 | $2.48 | $2.45 | $60.65K | 24.55K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9213 | $2.37 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.48 | 9922 | 1 |
View Market Depth
| Last trade - 15.39pm 10/09/2025 (20 minute delay) ? |
| VLS (ASX) Chart |